{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T03:14:56Z","timestamp":1761707696588},"reference-count":15,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2004,9,1]],"date-time":"2004-09-01T00:00:00Z","timestamp":1093996800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2004,9]]},"DOI":"10.1016\/j.pnpbp.2004.05.041","type":"journal-article","created":{"date-parts":[[2004,7,30]],"date-time":"2004-07-30T05:37:34Z","timestamp":1091165854000},"page":"1061-1063","source":"Crossref","is-referenced-by-count":21,"title":["Encephalopathy and myoclonus triggered by valproic acid"],"prefix":"10.1016","volume":"28","author":[{"given":"Andreas","family":"Reif","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Leonhard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rainald","family":"M\u00f6\u00dfner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Klaus-Peter","family":"Lesch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas J.","family":"Fallgatter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2004.05.041_bib1","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0013-4694(94)00268-P","article-title":"Negative myoclonus during valproate-related stupor. Neurophysiological evidence of a cortical non-epileptic origin","volume":"94","author":"Aguglia","year":"1995","journal-title":"Electroencephalogr. Clin. Neurophysiol."},{"key":"10.1016\/j.pnpbp.2004.05.041_bib2","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1212\/WNL.47.3.626","article-title":"Reversible parkinsonism and cognitive impairment with chronic valproate use","volume":"47","author":"Armon","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.pnpbp.2004.05.041_bib3","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/BF00873521","article-title":"Valproate encephalopathy and hypocarnitinaemia in diabetic patients","volume":"241","author":"Averbuch-Heller","year":"1994","journal-title":"J. Neurol."},{"key":"10.1016\/j.pnpbp.2004.05.041_bib4","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1034\/j.1399-5618.2003.00031.x","article-title":"Valproate","volume":"5","author":"Bowden","year":"2003","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.pnpbp.2004.05.041_bib5","first-page":"474","article-title":"Valproate-induced encephalopathy","volume":"64","author":"Chen","year":"2001","journal-title":"Zhonghua Yixue Zazhi (Taipei)"},{"key":"10.1016\/j.pnpbp.2004.05.041_bib6","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/00007691-199702000-00012","article-title":"Status epilepticus associated with the combination of valproic acid and clomipramine","volume":"19","author":"DeToledo","year":"1997","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.pnpbp.2004.05.041_bib7","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1177\/088307380001500713","article-title":"Temporary pure red-cell aplasia during valproate monotherapy: clinical observations and spectral electroencephalographic aspects","volume":"15","author":"Farkas","year":"2000","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.pnpbp.2004.05.041_bib8","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/00004714-200008000-00019","article-title":"Increase in serum clomipramine concentrations caused by valproate","volume":"20","author":"Fehr","year":"2000","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2004.05.041_bib9","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/BF02043308","article-title":"Stuporous states or coma induced by the rapid administration of high doses of sodium valproate","volume":"3","author":"Gastaut","year":"1982","journal-title":"Ital. J. Neurol. Sci."},{"key":"10.1016\/j.pnpbp.2004.05.041_bib10","doi-asserted-by":"crossref","first-page":"695","DOI":"10.2165\/00023210-200216100-00004","article-title":"Pharmacological and therapeutic properties of valproate: a summary after 35 years of clinical experience","volume":"16","author":"Perucca","year":"2002","journal-title":"CNS Drugs"},{"key":"10.1016\/j.pnpbp.2004.05.041_bib11","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/gps.729","article-title":"Acute akinetic crisis with marked cognitive impairment due to valproate treatment","volume":"18","author":"Reif","year":"2003","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.pnpbp.2004.05.041_bib12","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s001150050575","article-title":"Valproic acid in prophylaxis of bipolar disorder. A case of valproate-induced encephalopathy","volume":"71","author":"Rottach","year":"2000","journal-title":"Nervenarzt"},{"key":"10.1016\/j.pnpbp.2004.05.041_bib13","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0940-2993(96)80094-7","article-title":"Morphological features of encephalopathy after chronic treatment of the antiepileptic drug valproate to rats. A transmission electron microscopic study of capillaries in the cerebellar cortex","volume":"48","author":"Sobaniec-Lotowska","year":"1996","journal-title":"Exp. Toxicol. Pathol."},{"key":"10.1016\/j.pnpbp.2004.05.041_bib14","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1023\/A:1021918104127","article-title":"Valproate-induced hyperammonemic encephalopathy","volume":"17","author":"Verrotti","year":"2002","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.pnpbp.2004.05.041_bib15","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1046\/j.1528-1157.2002.25001.x","article-title":"Serum and CSF glutamine levels in valproate-related hyperammonemic encephalopathy","volume":"43","author":"Vossler","year":"2002","journal-title":"Epilepsia"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584604001010?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584604001010?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,5]],"date-time":"2019-02-05T09:25:55Z","timestamp":1549358755000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584604001010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,9]]},"references-count":15,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2004,9]]}},"alternative-id":["S0278584604001010"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2004.05.041","relation":{},"ISSN":["0278-5846"],"issn-type":[{"type":"print","value":"0278-5846"}],"subject":[],"published":{"date-parts":[[2004,9]]}}}